Treatment of graft-versus-host-disease with mesenchymal stromal cells

By Kebriaei Partow   Robinson Simon  

Cytotherapy, Vol. 13, Iss. 3, 2011-03 ,pp. : 262-268

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner

By Joo Sun-Young   Cho Kyung-Ah   Jung Yun-Jae   Kim Han-Seong   Park Seong-Yeol   Choi Yong-Bock   Hong Kyeong-Man   Woo So-Youn   Seoh Ju-Young   Cho Su Jin   Ryu Kyung-Ha  

Cytotherapy, Vol. 12, Iss. 3, 2010-04 ,pp. : 361-370

Ashgate Publishing Ltd

Access to resources Recommend Favorite

A new induction protocol for the control of steroid refractory/dependent acute graft versus host disease with alefacept and tacrolimus

By Shapira Michael   Resnick Igor   Dray Liliane   Aker Memet   Stepensky Polina   Elad Sharon   Gesundeheidt Benjamin   Samuel Simcha   Or Reuven  

Cytotherapy, Vol. 11, Iss. 1, 2009-02 ,pp. : 61-67

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Mesenchymal Stem Cells for Treatment and Prevention of Graft-Versus- Host Disease After Allogeneic Hematopoietic Cell Transplantation

By  

Current Stem Cell Research & Therapy, Vol. 4, Iss. 4, 2009-12 ,pp. : 252-259

Bentham Science Publishers

Access to resources Recommend Favorite

Human umbilical cord blood-derived stromal cells prevent graft-versus-host disease in mice following haplo-identical stem cell transplantation

By Hao Lei   Gao Lei   Chen Xing-Hua   Zou Zhong-Min   Zhang Xi   Kong Pei-Yan   Zhang Cheng   Peng Xian-Gui   Sun Ai-Hua   Wang Qing-Yu  

Cytotherapy, Vol. 13, Iss. 1, 2011-01 ,pp. : 83-91

Ashgate Publishing Ltd

Access to resources Recommend Favorite